<!DOCTYPE html>
<html>
<head> <meta charset="utf-8"/>
 <title>Decision Tools</title>
</head>
<body>
<h1> Decision Tools </h1>
<b>1.  AAA screening: </b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://canadiantaskforce.ca/tools-resources/abdominal-aortic-aneurysm-harms-and-benefits/" target="_blank"> Men 65-80</a><br>
<b>2. Breast Cancer screening: </b> <br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://canadiantaskforce.ca/tools-resources/abdominal-aortic-aneurysm-harms-and-benefits/" target="_blank"> Women 40-49 not at increased risk</a><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://canadiantaskforce.ca/wp-content/uploads/2019/01/CTFPHC_Breast_Cancer_1000_Person-Single-Pages-50-59-Final_v11.pdf" target="_blank"> Women 50-59 not at increased risk</a><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://canadiantaskforce.ca/wp-content/uploads/2019/01/CTFPHC_Breast_Cancer_1000_Person-Single-Pages-60-69-Final_v11.pdf" target="_blank"> Women 60-69 not at increased risk</a><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://canadiantaskforce.ca/wp-content/uploads/2019/01/CTFPHC_Breast_Cancer_1000_Person-Single-Pages-70-74-Final_v11.pdf" target="_blank"> Women 70-74 not at increased risk</a><br>	
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull;<a href="http://www.bccancer.bc.ca/screening/breast/get-a-mammogram/benefits-and-limitations" target="_blank"> BCCA decision tool re: benefits and harms re: breast Ca screening</a><br>	
<b>3. Colorectal Cancer screening: </b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://canadiantaskforce.ca/wp-content/uploads/2016/05/ctfphccolorectal-cancerpatient-faqfinal-updated160222.pdfhttps://canadiantaskforce.ca/wp-content/uploads/2016/05/ctfphccolorectal-cancerpatient-faqfinal-updated160222.pdf" target="_blank"> Ages 50-74</a><br>
<b>4.  DM screening:</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://canadiantaskforce.ca/wp-content/uploads/2016/05/2012-type-2-diabetes-patient-findrisc-en.pdf" target="_blank"> Type 2 DM Risk Calculator</a><br>
<b>5.  Lung cancer screening:</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://canadiantaskforce.ca/wp-content/uploads/2016/05/ctfphclung-cancerharms-and-benefitsfinal.pdf" target="_blank"> Ages 55-74 (30 pack year smoking history)</a><br>
<b>6. PSA screening :</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://canadiantaskforce.ca/wp-content/uploads/2016/12/CTFPHC_Prostate-Cancer_HarmsBenefits_FINAL.pdf" target="_blank"> Men 55-69</a><br>
<b>7. DM medication options:</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://diabetesdecisionaid.mayoclinic.org/index" target="_blank"> Diabetes decision aid</a><br>
<b>8. Osteoporosis medication:</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://osteoporosisdecisionaid.mayoclinic.org" target="_blank"> Decision tool</a><br>
<b>9. Rheumatoid Arthritis:</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://cdn.prod-carehubs.net/n1/56fab03a15e99046/uploads/2016/07/RA-Choice-Decision-Aid-English.pdf" target="_blank"> Medication choices</a><br>
<b>10. Depression:</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://depressiondecisionaid.mayoclinic.org/index" target="_blank"> Antidepressant choices</a><br>
<b>11. Angina Class I-II:</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://cdn.prod-carehubs.net/n1/56fab03a15e99046/uploads/2014/05/stent-vs-omt-DA_vs24classI_II.pdf" target="_blank"> PCI choice</a><br>
<b>12. Angina Class III:</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://cdn.prod-carehubs.net/n1/56fab03a15e99046/uploads/2014/05/stent-vs-omt-DA_vs24classIII.pdf" target="_blank"> PCI choice</a><br>
<b>13.  Explaining risk reduction:</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://www.stewartmedicine.com/blog/risk-reduction/" target="_blank"> Risk Reduction</a><br>
<b>14. Explaining absolute vs relative risk:</b><br>				  		
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://www.youtube.com/watch?feature=youtu.be&v=ew_5eTcm7bk&app=desktop" target="_blank"> Video for patients</a><br>
<b>15. Statin choice:</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://statindecisionaid.mayoclinic.org" target="_blank"> Statin decision aid</a><br>
<b>16. COPD:</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="http://doctorwidget.com/alf/ignition/index.php/alf_pcrt#" target="_blank"> Lung Age estimator</a><br>
<b>17. Xray Risk:</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://www.xrayrisk.com/calculator/calculator.php" target="_blank"> Xray Risk Calculator</a><br>
<b>18. CVD Risk Assessment:</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="http://chd.bestsciencemedicine.com/calc2.html" target="_blank"> Online version of CVD risk assessment including New Zealand calculator</a><br>
<b>19. Needlestick injury risk:</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull; <a href="https://www.mdcalc.com/hiv-needle-stick-risk-assessment-stratification-protocol-rasp" target="_blank"> Needlestick injury risk and need for post-exposure prophylaxis</a><br>


 	
			
</body>
</html>